Back to INCY
Phase 3
Development Phase
2
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
2 competitors in MPN (Myeloproliferative Neoplasms)
View Full LandscapeDrug Information
Target Indication
MPN (Myeloproliferative Neoplasms)
Clinical Trial
NCT01348490Last updated: 12/29/2025
Patent & Exclusivity
ActiveRLD
Latest Patent Expiry
May 5, 2041(14y 7m)
Patents Listed
54
Exclusivity
I-896NPPPEDODE*PEDM-285ODE-238ODE-373PED
Application
NDA 217180Drug Science
Mechanism of action & safety profile
Developer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts